Caribou Biosciences Brass Face Investor's Clinical Trials Suit

By Sydney Price · March 12, 2025, 7:53 PM EDT

Executives and directors of Caribou Biosciences Inc. have been hit with a shareholder's derivative suit alleging that they overstated the safety and efficacy of Caribou's cell therapy and concealed that the...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Allen v. Braunstein et al

Case Number

3:25-cv-02463

Court

California Northern

Nature of Suit

Stockholders Suits

Date Filed

March 11, 2025